Alpha 2.0
Login Register
» Authors » E M Lemmel

E M Lemmel

Explore the profile of E M Lemmel including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 109
Citations 424
Followers 0
Related Specialties
General Medicine
Allergy & Immunology
Rheumatology
Top 10 Co-Authors
U Botzenhardt
R Kreienberg
F Melchert
H Schulte-Wissermann
R A GOOD
P Herzer
W Goldhofer
P Alfoldy
K Nouza
J Muller
Published In
Verh Dtsch Ges Inn Med
Int Arch Allergy Appl Immunol
Z Rheumatol
Arch Immunol Ther Exp (Warsz)
Arzneimittelforschung
Affiliations
Soon will be listed here.
Recent Articles
1.
Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis
Altman R, Abadie E, Avouac B, Bouvenot G, Branco J, Bruyere O, et al.
Osteoarthritis Cartilage . 2005 Jan; 13(1):13-9. PMID: 15639632
Objective: The Group for the Respect of Ethics and Excellence in Science (GREES) organized a working group to assess the value of time to joint surgery as a potential therapeutic...
2.
When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?
Dougados M, Emery P, Lemmel E, Zerbini C, Brin S, van Riel P
Ann Rheum Dis . 2004 Jul; 64(1):44-51. PMID: 15271770
Objective: To evaluate the efficacy and safety of adding sulfasalazine to leflunomide treatment compared with switching to sulfasalazine alone in patients with RA with an inadequate response to leflunomide monotherapy....
3.
[Preliminary consensus statement on glucocorticoid-induced osteoporosis]
Scharla S, Buttgereit F, Dreher R, Felsenberg D, Franck H, Hein G, et al.
Z Rheumatol . 2001 Jun; 60(2):96-9. PMID: 11383055
No abstract available.
4.
[Therapy of ankylosing spondylitis (AS) with radium chloride (224SpondylAT)]
Braun J, Lemmel E, Manger B, Rau R, Sorensen H, Sieper J
Z Rheumatol . 2001 Jun; 60(2):74-83. PMID: 11383052
No abstract available.
5.
Do estrogens effectively prevent osteoporosis-related fractures? The Group for the Respect of Ethics and Excellence in Science
Reginster J, Bruyere O, Audran M, Avouac B, Body J, Bouvenot G, et al.
Calcif Tissue Int . 2000 Aug; 67(3):191-4. PMID: 10954771
No abstract available.
6.
A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis
Emery P, Breedveld F, Lemmel E, Kaltwasser J, Dawes P, Gomor B, et al.
Rheumatology (Oxford) . 2000 Jul; 39(6):655-65. PMID: 10888712
Objective: To compare the clinical efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis (RA). Methods: In this multicentre, double-blind trial, 999 subjects with active RA...
7.
Recommendations for the registration of drugs intended for use in the treatment of male osteoporosis
Kaufman J, Compston J, Audran M, Avouac B, Devogelaer J, Lemmel E, et al.
Calcif Tissue Int . 1999 Jun; 65(1):4-7. PMID: 10369725
No abstract available.
8.
Inhibition of interleukin-8 synthesis by intraarticular methotrexate therapy in patients with rheumatoid arthritis
Gao I, Leins C, Bohlen H, Heilig B, Lemmel E
Z Rheumatol . 1998 Jun; 57(2):95-100. PMID: 9627948
5 Patients with definite RA and knee effusions under constant doses of DMARD therapy were treated with up to 6 intraarticular injections of 10 mg methotrexate (MTX) every 3 to...
9.
[Rheumatology]
Lemmel E, Gross W, Herzer P, Marker-Herrmann E, Manger E
Internist (Berl) . 1998 May; 39(4):368-72. PMID: 9599748
No abstract available.
10.
Efficacy and safety of meloxicam in patients with rheumatoid arthritis
Lemmel E, Bolten W, Burgos-Vargas R, Platt P, Nissila M, Sahlberg D, et al.
J Rheumatol . 1997 Feb; 24(2):282-90. PMID: 9034984
Objective: To evaluate the efficacy and safety of meloxicam, a new acidic enolic nonsteroidal anti-inflammatory drug, at doses of 7.5 and 15 mg once daily in patients with rheumatoid arthritis...